Impact of Chronic Obstructive Pulmonary Disease in Heart Failure with Preserved Ejection Fraction.

[1]  Zhuyin Li,et al.  Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone. , 2020, JACC. Heart failure.

[2]  R. Townsend,et al.  Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[3]  Y. Takeishi,et al.  Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry. , 2019, Journal of cardiology.

[4]  R. Townsend,et al.  Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction , 2019, Journal of the American Heart Association.

[5]  S. Selvaraj,et al.  Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure , 2019, Journal of the American Heart Association.

[6]  M. Schnall,et al.  Arterial Properties as Determinants of Left Ventricular Mass and Fibrosis in Severe Aortic Stenosis: Findings From ACRIN PA 4008 , 2018, Journal of the American Heart Association.

[7]  Michael T. Lu,et al.  The effect of emphysema on readmission and survival among smokers with heart failure , 2018, PloS one.

[8]  W. Witschey,et al.  Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes , 2018, Diabetes Care.

[9]  J. Chirinos.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations , 2017, Journal of Cardiovascular Translational Research.

[10]  R. Townsend,et al.  Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide Metabolites , 2016, Journal of the American Heart Association.

[11]  F. Flachskampf,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  E. Lakatta,et al.  Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. , 2015, Hypertension.

[13]  Robert J Mentz,et al.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. , 2014, Journal of the American College of Cardiology.

[14]  Chia-Ying Liu,et al.  Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.

[15]  C. O'connor,et al.  The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial. , 2012, Journal of cardiac failure.

[16]  G. Fonarow,et al.  Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE‐HF , 2012, European journal of heart failure.

[17]  Sameer Ather,et al.  Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. , 2012, Journal of the American College of Cardiology.

[18]  P. Segers,et al.  Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. , 2010, Hypertension.

[19]  Einar Heiberg,et al.  Design and validation of Segment - freely available software for cardiovascular image analysis , 2010, BMC Medical Imaging.

[20]  J. McMurray,et al.  Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology , 2009, European journal of heart failure.

[21]  C. Torp‐Pedersen,et al.  Chronic obstructive pulmonary disease in patients admitted with heart failure , 2008, Journal of internal medicine.

[22]  S. Solomon,et al.  Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. , 2008, JACC. Cardiovascular imaging.

[23]  Andreas Greiser,et al.  Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.

[24]  C. Lavie,et al.  Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. , 2006, The American journal of cardiology.

[25]  J. McMurray,et al.  Heart failure with preserved left ventricular systolic function: a hospital cohort study , 2005, Heart.

[26]  J. Marcus,et al.  Early changes of cardiac structure and function in COPD patients with mild hypoxemia. , 2005, Chest.

[27]  Albert W Wu,et al.  Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[28]  G. Reboldi,et al.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. , 1995, Journal of the American College of Cardiology.

[29]  D. Kass,et al.  Ventricular-vascular interaction in heart failure. , 2008, Heart failure clinics.